EnVVeno Medical Corporation (NASDAQ:NVNO) | WebDisclosure

Switch to English

10873	Sociétés
236391	Mots-clés
165271	Articles
126763	Communiqués

Accueil
Sociétés
EnVVeno Medical Corporation

COMMUNIQUÉ DE PRESSE

publié le 16/04/2024 à 15:00, il y a 2 années 4 mois

New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
enVVeno Medical Corporation to present additional topline efficacy data from VenoValve U.S. pivotal trial at 2024 Charing Cross International Symposium in London. Data to review clinical status of severe Chronic Venous Insufficiency patients post VenoValve implantation

VenoValve Chronic Venous Insufficiency EnVVeno Medical Corporation SAVVE Trial Charing Cross International Symposium
BRÈVE

publiée le 09/04/2024 à 14:50, il y a 2 années 4 mois

EnVVeno Medical Appoints Andrew Cormack as Chief Commercial Officer to Spearhead VenoValve® Commercialization

EnVVeno Medical VenoValve® Chronic Venous Insufficiency (CVI) SAVVE U.S. Pivotal Study Commercialization Strategy
BRÈVE

publiée le 09/04/2024 à 14:50, il y a 2 années 4 mois

EnVVeno Medical nomme Andrew Cormack au poste de directeur commercial pour diriger la commercialisation de VenoValve®

EnVVeno Medical VenoValve® Insuffisance Veineuse Chronique (IVC) Étude Pivot Américaine SAVVE Stratégie De Commercialisation
COMMUNIQUÉ DE PRESSE

publié le 09/04/2024 à 14:45, il y a 2 années 4 mois

enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer
enVVeno Medical Corporation appoints Andrew Cormack as Chief Commercial Officer to drive VenoValve's commercialization strategy. PMA application for FDA approval on track for Q4 2024

FDA Approval VenoValve EnVVeno Medical Corporation Commercialization Strategy Andrew Cormack
BRÈVE

publiée le 15/03/2024 à 14:05, il y a 2 années 5 mois

EnVVeno Medical to Showcase Its Innovations in an Upcoming Virtual Investor Event

EnVVeno Medical Medical Innovation Virtual Investor Event Venous Disease Treatment Corporate Overview
BRÈVE

publiée le 15/03/2024 à 14:05, il y a 2 années 5 mois

EnVVeno Medical présentera ses innovations lors d'un prochain événement virtuel pour les investisseurs

Innovation Médicale EnVVeno Medical Événement Virtuel Pour Les Investisseurs Traitement Des Maladies Veineuses Vue D'ensemble De L'entreprise
COMMUNIQUÉ DE PRESSE

publié le 15/03/2024 à 14:00, il y a 2 années 5 mois

enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity
enVVeno Medical to present at Virtual Investor Lunch Break on March 21, 2024, with CEO Robert Berman discussing the company's outlook and the enVVeno Opportunity

EnVVeno Medical Venous Disease Treatment Virtual Investor Lunch Break Robert Berman Bioprosthetic Solutions
BRÈVE

publiée le 06/03/2024 à 14:45, il y a 2 années 5 mois

EnVVeno Medical Corporation Announces Positive Results from VenoValve Pivotal Trial

FDA Approval EnVVeno Medical VenoValve Chronic Venous Insufficiency Clinical Improvement
BRÈVE

publiée le 06/03/2024 à 14:45, il y a 2 années 5 mois

EnVVeno Medical Corporation annonce les résultats positifs de l'essai pivot VenoValve

EnVVeno Medical Insuffisance Veineuse Chronique VenoValve Approbation De La FDA Amélioration Clinique
COMMUNIQUÉ DE PRESSE

publié le 06/03/2024 à 14:40, il y a 2 années 5 mois

Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
enVVeno Medical presents positive topline efficacy data from the SAVVE U.S. pivotal trial for the VenoValve at the 2024 American Venous Forum Annual Meeting, showing significant clinical improvement in CVI patients

EnVVeno Medical VenoValve Clinical Improvement SAVVE Trial CVI Patients

Les Echos

Publié le 24/08/2026 à 12:25, il y a 1 heure 34 minutes

GUILLEMOT CORPORATION | Weekly report share buyback from August 17 to August 21 2026
Publié le 24/08/2026 à 12:25, il y a 1 heure 34 minutes

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 17 au 21 août 2026
Publié le 24/08/2026 à 11:58, il y a 2 heures 1 minute

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 juillet 2026
Publié le 24/08/2026 à 11:58, il y a 2 heures 1 minute

Statement about the number of shares composing the share capital and the number of voting rights as of July 31, 2026
Publié le 21/08/2026 à 18:33, il y a 2 jours 19 heures

260821 BENETEAU Transaction sur actions propres

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 24/08/2026 à 13:45, il y a 15 minutes

Amarc Announces CAD$20 Million Private Placement Financing
Publié le 24/08/2026 à 13:30, il y a 30 minutes

ZTEST Electronics Inc. Announces the Grant of Stock Options to CEO and Directors
Publié le 24/08/2026 à 13:00, il y a 1 heure

Galway Metals Continues to Demonstrate Broad Gold Mineralization at Southwest Deposit; 2.0 g/t Gold Over 68.0 Metres
Publié le 24/08/2026 à 13:00, il y a 1 heure

Global Education Communities Corp. Provides Update on the Atmosphere Project
Publié le 24/08/2026 à 13:00, il y a 1 heure

Gold Terra Announces Sonic Drill Program to Evaluate Gold Content in Con Mine Historical Tailings, Yellowknife, NWT and Stock Options Grant

Voir tout ACCESSWIRE

EQS Group

Publié le 24/08/2026 à 13:49, il y a 11 minutes

EcoVadis recognizes SAF-HOLLAND with its first Silver Medal
Publié le 24/08/2026 à 13:40, il y a 19 minutes

Sunday Hotels Appoints New Cluster General Managers to Strengthen Local Leadership and Operations in Germany
Publié le 24/08/2026 à 13:25, il y a 34 minutes

Omdia H1 2026: Hisense Ranks No. 1 Globally in 100-Inch-and-Above TV Shipments
Publié le 24/08/2026 à 13:13, il y a 46 minutes

Gledhow Investments plc: Confirmation of Director Appointments, CLN Update and Options Package
Publié le 24/08/2026 à 13:05, il y a 54 minutes

Following Its $2 Million Kickstarter Success, xLean Brings AI Agent-Powered Floor-Washing Robot to IFA 2026